BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas J Kluiver, S Poppema, D de Jong, T Blokzijl, G Harms, S Jacobs, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 945 | 2005 |
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 697 | 2011 |
High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma A Van den Berg, L Visser, S Poppema The American journal of pathology 154 (6), 1685-1691, 1999 | 448 | 1999 |
Cigarette smoke–induced emphysema: a role for the B cell? BWA van der Strate, DS Postma, CA Brandsma, BN Melgert, MA Luinge, ... American journal of respiratory and critical care medicine 173 (7), 751-758, 2006 | 430 | 2006 |
Somatic mutations of the von Hippel—Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma K Foster, A Prowse, A van den Berg, S Fleming, MMF Hulsbeek, ... Human molecular genetics 3 (12), 2169-2173, 1994 | 429 | 1994 |
High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma A Van den Berg, BJ Kroesen, K Kooistra, D de Jong, J Briggs, T Blokzijl, ... Genes, Chromosomes and Cancer 37 (1), 20-28, 2003 | 340 | 2003 |
MicroRNAs, macrocontrol: regulation of miRNA processing I Slezak-Prochazka, S Durmus, BJ Kroesen, A van den Berg Rna 16 (6), 1087-1095, 2010 | 311 | 2010 |
Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma J Kluiver, E Haralambieva, D de Jong, T Blokzijl, S Jacobs, BJ Kroesen, ... Genes, Chromosomes and Cancer 45 (2), 147-153, 2006 | 309 | 2006 |
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma L Qi, J Bart, L Tan, I Platteel, T Sluis, S Huitema, G Harms, L Fu, ... BMC cancer 9 (1), 163, 2009 | 278 | 2009 |
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin MR Price, PD Rye, E Petrakou, A Murray, K Brady, S Imai, S Haga, ... Tumor Biology 19 (Suppl. 1), 1-20, 1998 | 277 | 1998 |
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor TJN Hiltermann, MM Pore, A van den Berg, W Timens, HM Boezen, ... Annals of oncology 23 (11), 2937-2942, 2012 | 272 | 2012 |
Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies B Bakker, A Taudt, ME Belderbos, D Porubsky, DCJ Spierings, ... Genome biology 17, 1-15, 2016 | 241 | 2016 |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) V Enciso-Mora, P Broderick, Y Ma, RF Jarrett, H Hjalgrim, K Hemminki, ... Nature genetics 42 (12), 1126-1130, 2010 | 238 | 2010 |
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer R Koster, A Di Pietro, H Timmer-Bosscha, JH Gibcus, A Van Den Berg, ... The Journal of clinical investigation 120 (10), 3594-3605, 2010 | 238 | 2010 |
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma M Niens, RF Jarrett, B Hepkema, IM Nolte, A Diepstra, M Platteel, ... Blood, The Journal of the American Society of Hematology 110 (9), 3310-3315, 2007 | 207 | 2007 |
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma A Diepstra, M Niens, E Vellenga, GW Van Imhoff, IM Nolte, M Schaapveld, ... The Lancet 365 (9478), 2216-2224, 2005 | 206 | 2005 |
Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t (14; 18), 3q27, or other translocations: t (14; 18) and 3q27 are mutually exclusive AG Bosga-Bouwer, GW van Imhoff, R Boonstra, A van der Veen, ... Blood, The Journal of the American Society of Hematology 101 (3), 1149-1154, 2003 | 200 | 2003 |
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile JH Gibcus, LP Tan, G Harms, RN Schakel, D de Jong, T Blokzijl, P Möller, ... Neoplasia 11 (2), 167-IN9, 2009 | 198 | 2009 |
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues E Maggio, A van den Berg, A Diepstra, J Kluiver, L Visser, S Poppema Annals of oncology 13, 52-56, 2002 | 197 | 2002 |
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma J Kluiver, A van den Berg, D de Jong, T Blokzijl, G Harms, E Bouwman, ... Oncogene 26 (26), 3769-3776, 2007 | 195 | 2007 |